Mesa Laboratories, Inc. (NASDAQ:MLAB) Stock Holdings Trimmed by Jane Street Group LLC

Jane Street Group LLC lessened its holdings in shares of Mesa Laboratories, Inc. (NASDAQ:MLAB) by 89.7% in the third quarter, according to its most recent filing with the SEC. The firm owned 2,308 shares of the medical instruments supplier’s stock after selling 20,134 shares during the quarter. Jane Street Group LLC’s holdings in Mesa Laboratories were worth $300,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Meros Investment Management LP bought a new position in shares of Mesa Laboratories during the 2nd quarter valued at about $2,456,000. State Street Corp boosted its holdings in Mesa Laboratories by 9.2% during the third quarter. State Street Corp now owns 214,148 shares of the medical instruments supplier’s stock worth $27,809,000 after buying an additional 18,128 shares in the last quarter. Charles Schwab Investment Management Inc. grew its position in Mesa Laboratories by 38.6% in the third quarter. Charles Schwab Investment Management Inc. now owns 62,609 shares of the medical instruments supplier’s stock worth $8,130,000 after buying an additional 17,450 shares during the last quarter. Eagle Asset Management Inc. increased its holdings in shares of Mesa Laboratories by 10.9% in the third quarter. Eagle Asset Management Inc. now owns 165,955 shares of the medical instruments supplier’s stock valued at $19,722,000 after buying an additional 16,293 shares in the last quarter. Finally, Dimensional Fund Advisors LP lifted its position in shares of Mesa Laboratories by 7.1% during the 2nd quarter. Dimensional Fund Advisors LP now owns 131,891 shares of the medical instruments supplier’s stock valued at $11,444,000 after acquiring an additional 8,722 shares during the last quarter. Institutional investors own 90.60% of the company’s stock.

Analyst Ratings Changes

Several analysts have issued reports on MLAB shares. Evercore ISI boosted their price objective on Mesa Laboratories from $120.00 to $160.00 and gave the stock an “outperform” rating in a report on Tuesday, October 1st. StockNews.com lowered shares of Mesa Laboratories from a “buy” rating to a “hold” rating in a report on Wednesday, November 13th.

Mesa Laboratories Stock Up 2.2 %

MLAB stock opened at $142.03 on Friday. The company has a 50 day moving average of $123.23 and a two-hundred day moving average of $119.76. The company has a quick ratio of 0.51, a current ratio of 0.70 and a debt-to-equity ratio of 0.65. Mesa Laboratories, Inc. has a 12-month low of $83.68 and a 12-month high of $147.34. The company has a market cap of $771.36 million, a price-to-earnings ratio of -3.12 and a beta of 0.82.

Mesa Laboratories Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, March 17th. Stockholders of record on Friday, February 28th will be paid a dividend of $0.16 per share. The ex-dividend date is Friday, February 28th. This represents a $0.64 annualized dividend and a dividend yield of 0.45%. Mesa Laboratories’s dividend payout ratio (DPR) is presently -1.40%.

Insider Activity

In other Mesa Laboratories news, CEO Gary M. Owens sold 2,518 shares of the company’s stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $113.62, for a total value of $286,095.16. Following the completion of the transaction, the chief executive officer now owns 45,888 shares of the company’s stock, valued at $5,213,794.56. This represents a 5.20 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 4.40% of the stock is currently owned by insiders.

Mesa Laboratories Profile

Mesa Laboratories, Inc develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries.